Registration deadline is September 1st

Keynotes:

• Lynne Maquat, University of Rochester, Rochester
• Stanley Perlman, University of Iowa, Iowa
• Mariano A. Garcia-Blanco, UTMB, Texas

Moderation and discussion:

• Phillip Sharp, MIT, Cambridge

Speakers:

• Amy S. Gladfelter, University of North Carolina, Chapel Hill
• Silvia Rouskin, Whitehead Institute, Cambridge
• Benjamin tenOever, Icahn School of Medicine at Mount Sinai, New York
• Sara Cherry, University of Pennsylvania School of Medicine, Philadelphia
• Sasha Gorbalenya, Leiden University, Leiden
• David H. Mathews, University of Rochester, Rochester
• Amanda Hargrove, Duke University, Durham
• Matthew Disney, The Scripps Research Institute, Jupiter
• Anastasia Khvorova, University of Massachusetts, Worcester
• Peter Unrau, Simon Fraser University, Burnaby
• Ying Fu Li, McMaster University, Hamilton
• Matthew Frieman, University of Maryland at Baltimore
• Tao Pan, University of Chicago, Illinois
• Stacy Horner, Duke University, Durham
• Cara Pager, State University of New York, Albany
• Bruno Canard, Laboratoire Architecture et Fonction des Macromolécules Biologiques, Marseille
• Volker Lohmann, University of Heidelberg, Heidelberg
• Wei-Shau Hu, NIH/NCI, Frederick
• Florian Krammer , Icahn School of Medicine at Mount Sinai, New York
• Alyson Kelvin, Dalhousie University, Halifax
• Pieter Cullis, University of British Columbia, Vancouver
• Darryl Falzarano, University of Saskatchewan, Saskatoon
• Jeffery S. Kieft, University of Colorado, Aurora
• Jon Dinman, University of Maryland, Baltimore
• Karen Mossman, McMaster University, Hamilton
• Marceline Côté, University of Ottawa, Ottawa
• Carrie Bourassa, University of Saskatchewan, Saskatoon

Topics:

1. Transcriptomics of the host and virus

2. Computational and experimental analysis of RNA viruses’ structure and function

3. Non-coding RNA tailored drug designs

4. Toolbox for RNA detection

5. Impact of RNA modifications on structure and function

6. RNA virus life cycles

7. RNA based vaccine delivery, developments and challenges

8. Hijacking translation the COVID style

9. Vaccines and innate immune response

10. General introduction of the epidemiology and public policy

Program

Meeting plan summary:

• Registration starts July 1st and the deadline for abstracts is July 30th.
• 3 keynotes and panel discussions at the end of every session.
• Poster sessions will be held before or after regular planner sessions on separate Zoom channels. The presenter will give a 5-minute presentation and answer the questions of those who choose to join the discussion.
• Posters will be advertised during the regular program by 2-minute presentations.
• Talks are 15 minutes long plus 5 minutes for questions.
• Sessions are normally 120 minutes long with a 10-minute break in between.
• 3 sessions per day. A total of 36 speakers, 50% invited and 50% selected from abstracts.
• Each session will end with a 15-minute public discussion.

There is no fee.

Free Registration is mandatory for all participants.

Types of Participation:

1 – Attendee

2 – Poster:
You have to submit an abstract after registering.
Posters will be assigned a special Zoom channel permitting presenters to describe their work and visitors may ask questions via chat or verbally.
The time assigned for a poster, including questions, is 10 minutes.

3 – Talk:
You have to submit an abstract after registering.
Session chairs will select oral presentations from submitted abstracts.
You need to select a topic that corresponds to your presentation.
The time assigned for a talk is 15 minutes for presentation + 5 minutes for questions.

General Registration
Registration starts July 1st
Registration deadline is September 10th

You have to register before submitting an abstract for a poster or a talk.
Submit an Abstract
deadline for abstract submission is August 1st
(2500 characters with spaces max)

A connection link will be sent to your registration email at least 2 days before the meeting.

The RiboClub

Guest organization committee:

Jonathan Dinman, University of Maryland
Peter Sarnow, Stanford University
Joyce Wilson, University of Saskatchewan 
Charles Rice, Rockefeller  Institute
Eric Jan, University of British Columbia 
Daniel Lafontaine, Université de Sherbrooke
Maria Duca, Université Côte d’Azur
Janet Rossant, The Gairdner Foundation
Brendan Bell, Université de Sherbrooke
Trushar Patel, University of Lethbridge
Sherif Abou Elela, Université de Sherbrooke
Mark A Kay, Stanford University

Collaborators:

HJ Weiden, University of Lethbridge (CSMB)
Barbara Papadopoulou, Université Laval
Danielle Vitali, Institute of infection and immunity (CIHR)